Hock Peng Koh

ORCID: 0000-0003-2676-7755
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Blood Pressure and Hypertension Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Heart Failure Treatment and Management
  • Asthma and respiratory diseases
  • Coronary Interventions and Diagnostics
  • Chemotherapy-related skin toxicity
  • Acute Ischemic Stroke Management
  • Electroconvulsive Therapy Studies
  • Patient Safety and Medication Errors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Respiratory Support and Mechanisms
  • Aortic aneurysm repair treatments
  • COVID-19 and healthcare impacts
  • Emergency and Acute Care Studies
  • Schizophrenia research and treatment
  • Treatment of Major Depression
  • Pneumonia and Respiratory Infections
  • Cardiac, Anesthesia and Surgical Outcomes
  • Antibiotic Use and Resistance
  • Cancer Treatment and Pharmacology

Ministry of Health
2020-2025

Hospital Kuala Lumpur
2020-2025

National University of Malaysia
2022

Abstract Background Cardiovascular disease (CVD) is the principal cause of death globally and in Malaysia. In Malaysia, a 4‐ to 6‐week subacute cardiac rehabilitation following hospital discharge available for individuals who have experienced myocardial infarction (MI) involves multidisciplinary approach that includes physicians, pharmacists, other health care professionals. Aim This study aimed assess illness perception, CVD risk factor knowledge, medication adherence among completed phase...

10.1002/jppr.1971 article EN Journal of Pharmacy Practice and Research 2025-01-23

Background: The emergency medicine (EM) pharmacist is an integrated part of the Emergency Department (ED) interdisciplinary team in many countries, including Malaysia. presence EM pharmacists ED has positively impacted patient outcomes. Data on pharmacists' interventions scarce Asian region. In Malaysia, data done by EDs was unavailable. This study aimed to assess type tertiary public hospitals

10.1080/20523211.2025.2457410 article EN cc-by-nc Journal of Pharmaceutical Policy and Practice 2025-01-27

What is known and objective Nebulizer use has been suspended in Malaysian public health facilities due to the potential aggravate COVID-19 nosocomial transmission. Currently, our facility uses pressurized metered-dose inhaler (pMDI) bronchodilator with Venturi mask modified spacer (VMMS) patients visiting Emergency Department (ED) for mild moderate exacerbation of asthma chronic obstructive pulmonary disease (COPD). We sought assess outcomes acceptance pMDI-VMMS outpatient ED a tertiary...

10.1111/jcpt.13410 article EN Journal of Clinical Pharmacy and Therapeutics 2021-03-25

Bleeding outcomes are crucial primary safety endpoints in studies involving thrombolytic agents. This study aimed to determine the incidence, characteristics and mortality of bleeding following ST-elevation myocardial infarction (STEMI) thrombolysis an Asian population.

10.5847/wjem.j.1920-8642.2024.077 article EN World Journal of Emergency Medicine 2024-01-01

Noradrenaline (norepinephrine) extravasation can lead to tissue ischemia due its vasoconstrictive properties. Phentolamine is the preferred treatment but often unavailable in many Malaysian healthcare facilities. Alternative treatments, such as topical glyceryl trinitrate (GTN) and terbutaline injections, have limited data supporting their use. This case series reports two instances of noradrenaline successfully managed with injections extemporaneously prepared GTN an Emergency Department...

10.31674/mjmr.2024.v08i03.004 article EN Malaysian Journal of Medical Research 2024-01-01

The Global Initiative for Asthma (GINA) has suggested the need more studies on inhaled corticosteroid (ICS)-formoterol in Emergency Department (ED).

10.1080/02770903.2024.2438094 article EN Journal of Asthma 2024-12-04

Three-factor Prothrombin Complex Concentrate (3F-PCC) containing factors II, IX and X was introduced to Malaysian public hospitals for warfarin reversal since 2017. Local studies on the outcomes of 3F-PCC use are limited. This study aimed determine extent target international normalized ratio (INR) achievement adverse drug reactions (ADRs) associated with in reversal. retrospective cohort analyzed data from adult patients who received anticoagulation between September 2017 January 2020....

10.1016/j.tru.2020.100014 article EN cc-by-nc-nd Thrombosis Update 2020-10-14

Abdominal aortic aneurysm (AAA) is not uncommon to cause coagulopathy. Warfarin use in patients presented with ruptured AAA can further complicate the preparation for surgical intervention and affect prognosis. We reported a case of impending rupture that progressed contained leak warfarin user, persistent elevated rebound international normalized ratio (INR) despite aggressive correction fresh frozen plasma (FFP) three-factor prothrombin complex concentrate (3F-PCC). Persistent coagulopathy...

10.31674/mjmr.2022.v06i04.007 article EN Malaysian Journal of Medical Research 2022-01-01
Coming Soon ...